Influenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran 1316943551, Iran.
Department of Laryngology, Faculty of Health Sciences in Katowice, Medical University of Silesia, 40-027 Katowice, Poland.
Biomolecules. 2020 Dec 24;11(1):10. doi: 10.3390/biom11010010.
The medical burden caused by respiratory manifestations of influenza virus (IV) outbreak as an infectious respiratory disease is so great that governments in both developed and developing countries have allocated significant national budget toward the development of strategies for prevention, control, and treatment of this infection, which is seemingly common and treatable, but can be deadly. Frequent mutations in its genome structure often result in resistance to standard medications. Thus, new generations of treatments are critical to combat this ever-evolving infection. Plant materials and active compounds have been tested for many years, including, more recently, active compounds like flavonoids. Quercetin is a compound belonging to the flavonols class and has shown therapeutic effects against influenza virus. The focus of this review includes viral pathogenesis as well as the application of quercetin and its derivatives as a complementary therapy in controlling influenza and its related symptoms based on the targets. We also touch on the potential of this class of compounds for treatment of SARS-COV-2, the cause of new pandemic.
作为一种传染性呼吸道疾病,流感病毒(IV)爆发引起的医疗负担巨大,以至于发达国家和发展中国家的政府都投入了大量的国家预算,用于制定预防、控制和治疗这种看似常见且可治疗但可能致命的感染的策略。其基因组结构的频繁突变常常导致对标准药物的耐药性。因此,新一代治疗方法对于对抗这种不断演变的感染至关重要。多年来,人们一直在测试植物材料和活性化合物,包括最近的类黄酮等活性化合物。槲皮素是一种属于黄酮醇类的化合物,已显示出对流感病毒的治疗作用。这篇综述的重点包括病毒发病机制,以及基于靶点将槲皮素及其衍生物作为控制流感及其相关症状的补充疗法的应用。我们还谈到了这类化合物治疗 SARS-COV-2(引发新的大流行的原因)的潜力。